BRPI0411174A - combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão - Google Patents

combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão

Info

Publication number
BRPI0411174A
BRPI0411174A BRPI0411174-5A BRPI0411174A BRPI0411174A BR PI0411174 A BRPI0411174 A BR PI0411174A BR PI0411174 A BRPI0411174 A BR PI0411174A BR PI0411174 A BRPI0411174 A BR PI0411174A
Authority
BR
Brazil
Prior art keywords
depression
treatment
combination
modafinil
antidepressant
Prior art date
Application number
BRPI0411174-5A
Other languages
English (en)
Inventor
Howard Hassman
Rodney J Hughes
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of BRPI0411174A publication Critical patent/BRPI0411174A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMBINAçãO DO MODAFINIL ANALéPTICO E UM ANTIDEPRESSIVO PARA O TRATAMENTO DA DEPRESSãO". Composições e métodos para tratamento de desordens depressivas por meio da administração de modafinil com antidepressivos.
BRPI0411174-5A 2003-05-13 2004-05-13 combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão BRPI0411174A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46994303P 2003-05-13 2003-05-13
US10/844,187 US20040229942A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations
PCT/US2004/015194 WO2004100937A1 (en) 2003-05-13 2004-05-13 Combination of the analeptic modafinil and an antidepressant for the treatment of depression

Publications (1)

Publication Number Publication Date
BRPI0411174A true BRPI0411174A (pt) 2006-07-18

Family

ID=33423928

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411174-5A BRPI0411174A (pt) 2003-05-13 2004-05-13 combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão

Country Status (25)

Country Link
US (1) US20040229942A1 (pt)
EP (1) EP1628652B1 (pt)
JP (1) JP5553955B2 (pt)
KR (1) KR20060019537A (pt)
AR (1) AR045423A1 (pt)
AU (1) AU2004238379B2 (pt)
BR (1) BRPI0411174A (pt)
CA (1) CA2525524C (pt)
CY (1) CY1113154T1 (pt)
DK (1) DK1628652T3 (pt)
EA (1) EA012173B1 (pt)
ES (1) ES2390225T3 (pt)
HK (1) HK1087645A1 (pt)
HR (1) HRP20120713T1 (pt)
IS (1) IS8097A (pt)
MX (1) MXPA05012144A (pt)
MY (1) MY140179A (pt)
NO (1) NO334448B1 (pt)
NZ (1) NZ544135A (pt)
PL (1) PL1628652T3 (pt)
PT (1) PT1628652E (pt)
SI (1) SI1628652T1 (pt)
TW (1) TWI409061B (pt)
UA (1) UA89753C2 (pt)
WO (1) WO2004100937A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168946A1 (en) * 2000-07-27 2010-03-31 Teva Pharmaceutical Industries Ltd Crystalline form of modafinil, and methods of preparing the crystalline form
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
EP1909573A4 (en) * 2005-07-21 2010-09-22 Neurohealing Pharmaceuticals I SHORT-TERM EFFECTIVE MODAFINIL COMPOSITIONS WITH A RAPID INITIAL EFFECT, AND METHOD FOR THEIR USE
CA2660565C (en) * 2006-08-14 2012-10-09 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
JP6614014B2 (ja) * 2016-04-26 2019-12-04 信越化学工業株式会社 含窒素オルガノキシシラン化合物およびその製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (pt) * 1993-06-22 1995-09-08 Lafon Labor
US5933841A (en) * 1996-05-17 1999-08-03 Ameritech Corporation Structured document browser
US5890172A (en) * 1996-10-08 1999-03-30 Tenretni Dynamics, Inc. Method and apparatus for retrieving data from a network using location identifiers
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6359635B1 (en) * 1999-02-03 2002-03-19 Cary D. Perttunen Methods, articles and apparatus for visibly representing information and for providing an input interface
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) * 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
AU6528400A (en) * 1999-08-23 2001-03-19 David M. Ockert Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations

Also Published As

Publication number Publication date
NO334448B1 (no) 2014-03-03
EA200501802A1 (ru) 2006-06-30
PL1628652T3 (pl) 2012-12-31
HK1087645A1 (en) 2006-10-20
PT1628652E (pt) 2012-09-28
DK1628652T3 (da) 2012-10-08
EP1628652A1 (en) 2006-03-01
NO20055450L (no) 2006-02-01
WO2004100937B1 (en) 2006-12-21
TW200500063A (en) 2005-01-01
IS8097A (is) 2005-10-27
CA2525524C (en) 2012-09-25
HRP20120713T1 (hr) 2012-09-30
SI1628652T1 (sl) 2012-11-30
JP5553955B2 (ja) 2014-07-23
UA89753C2 (ru) 2010-03-10
ES2390225T3 (es) 2012-11-07
AU2004238379A1 (en) 2004-11-25
EA012173B1 (ru) 2009-08-28
TWI409061B (zh) 2013-09-21
US20040229942A1 (en) 2004-11-18
EP1628652B1 (en) 2012-07-11
CY1113154T1 (el) 2016-04-13
WO2004100937A1 (en) 2004-11-25
CA2525524A1 (en) 2004-11-25
NZ544135A (en) 2008-09-26
MY140179A (en) 2009-11-30
JP2007505156A (ja) 2007-03-08
AR045423A1 (es) 2005-10-26
MXPA05012144A (es) 2006-02-08
NO20055450D0 (no) 2005-11-17
KR20060019537A (ko) 2006-03-03
AU2004238379B2 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
NO20055448L (no) Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon
BRPI0512220A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BRPI0512213A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BR0200155A (pt) Tratamento combinado para depressão
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
PT1238676E (pt) Combinacao de um inibidor de reabsorcao de serotonina com um antipsicotico para utilizacao na depressao na patologia obsessiva compulsiva e na psicose
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
CY1113154T1 (el) Συνδυασμος του αναληπτικου modafinil και ενος αντικαταθλιπτικου για τη θεραπεια της καταθλιψης
BRPI0607084A2 (pt) uso de um composto 11-desóxiprostaglandina, composição compreendendo o mesmo, e composto
ATE459353T1 (de) Gaboxadol zur behandlung von depressionen und anderen affektiven störungen
CL2011002233A1 (es) Metodo para tratar o prevenir el cancer, que comprende administrar una combinacion farmaceutica sinergica de: a) (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopropan-1-sulfonamida y b) 3-(6,7-bis(2-metoxietoxi)quinazolin-4-ilamino)benzonitrilo; composicion farmaceutica; y kit farmaceutico.
AR054435A1 (es) Agente para profilaxis o terapia contra la depresion o desorden de ansiedad
BR0210650A (pt) Tablete, e, uso do mesmo
BR0201524A (pt) Tratamento de combinação para ansiedade e depressão
BRPI0506631A (pt) combinações de um agente antiemético, composição farmacêutica e usos das combinações
TW200509895A (en) Analeptic and antidepressant combinations
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
TW200509894A (en) Analeptic and antidepressant combinations
BRPI0408320A (pt) composto, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio afetivo
AR057277A1 (es) Utilizacion de agomelatina para la obtencion de medicamentos destinados al tratamiento de los trastornos bipolares
BRPI0519807A2 (pt) uso de um canal trpc para o tratamento de uma doença cardiovascular
BR0317925A (pt) Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite
NO20060229L (no) Gaboxadol for behandling av depresjon og andre affektive lidelser
CL2004001040A1 (es) Uso de modafinilo para preparar un medicamento util para tratar un desorden depresivo.
AR044360A1 (es) Composiciones farmaceuticas que comprenden un analeptico y otros farmacos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 7A, 8A, 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A, 8A, 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.